ProQuest Financial LLC

CIK 1674772 · last filed 2017-03-29

ProQuest Financial LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 1 company since 2016. The most recent filing shows the insider sold $44.2M of EGRX on Mar 29, 2017. Across all open-market trades the lifetime net is −$77.2M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

3

Lifetime Open-Market Net

-$77.20M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted 10%+ Owner 7,277 $2.14 $15.6K -$77.20M 3 2017-03-29

Recent Filings

3 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-03-29 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −532,340 -$44.19M EDGAR
2016-09-23 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Sell (S) −498,975 -$33.02M EDGAR
2016-06-30 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Other (J) −49,515 $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.